Supraventricular arrhythmia

There are 10 papers on supraventricular arrhythmia in aging research: 1 trial and 9 observational studies in people.

Disease

10 papers study it5 more mention it6 findings

3 new papers in 30 daysSee all 15 papers on supraventricular arrhythmia

“SVT and VT profoundly elevated risks for incident heart failure (HR 79.0 and 32.2, p<0.01) and mortality (HR 11.3 and 8.0, p≤0.01).”
Prevalence and disease expression of pathogenic and likely pathogenic variants associated with ARVC in a large cohortESC Congress 2026 abstract2026doi:10.1093/eurheartj/ehag785.795
  • Human trial1
  • Humans9

Associations

5

Mortality

upin humans2HR 1.23–11.3

2 studies
  1. Supraventricular arrhythmia is associated with mortality in humans (ARVC-associated pathogenic/likely pathogenic variant carriers) (HR 11.3).

    HumansARVC-associated pathogenic/likely pathogenic variant carriers

  2. Supraventricular arrhythmia is associated with mortality in humans (Primary care screening population; compared with exclusively normal sinus rhythm) (HR 1.23, 95% CI 1.02–1.49).

    HumansPrimary care screening population; compared with exclusively normal sinus rhythm6.5 years maximum follow-upn = 14,403

Incident heart failure

upin humans1

1 study
  1. Supraventricular arrhythmia is associated with incident heart failure in humans (ARVC-associated pathogenic/likely pathogenic variant carriers) (HR 79.0).

    HumansARVC-associated pathogenic/likely pathogenic variant carriers

More on Incident heart failure

Left atrial conduit strain

upin humans1

1 study
  1. Left atrial conduit strain predicts supraventricular arrhythmia in T2DM (AUC 0.692).

    Humansin T2DM12 monthsn = 57

More on Left atrial conduit strain

Type 2 diabetes

upin humans1

1 study
  1. Type 2 diabetes is linked with a higher risk of supraventricular arrhythmia in humans (35.1% vs. 2.0% (p < 0.001)).

    Humans12 monthsn = 107

More on Type 2 diabetes

Clonal hematopoiesis of indeterminate potential

upin humans1HR 1.11

1 study
  1. Clonal hematopoiesis of indeterminate potential is linked with a higher risk of supraventricular arrhythmia in humans (HR 1.11 (95% CI 1.04-1.18); large CHIP HR 1.13 (95% CI 1.05-1.22)).

    Humansvariant allele fraction ≥2%n = 13,892

More on Clonal hematopoiesis of indeterminate potential

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 2Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 1Oct 2026: 2Nov 2026: 06 papers in 12 months

See all 15 papers on supraventricular arrhythmia